Furthermore, phosphorylation expression of mammalian target of rapamycin (mTOR), protein kinase B (AKT), extracellular signal-regulated kinase (ERK), and activation of rat sarcoma virus (RAS) were significantly reduced after AT treatment in vitro [40]. The gene discussed is MTOR; the disease is ataxia telangiectasia.